PMID- 23530143 OWN - NLM STAT- MEDLINE DCOM- 20130729 LR - 20211021 IS - 1550-6606 (Electronic) IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 190 IP - 9 DP - 2013 May 1 TI - NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-kappaB activity. PG - 4786-94 LID - 10.4049/jimmunol.1201809 [doi] AB - Although reactive oxygen species (ROS) produced by NADPH oxidase are known to regulate inflammatory responses, the impact of ROS on intracellular signaling pathways is incompletely understood. In these studies, we treated wild-type (WT) and p47(phox)-deficient mice with LPS to investigate mechanisms by which NADPH oxidase regulates signaling through the NF-kappaB pathway. After intratracheal instillation of LPS, ROS generation was impaired in p47(phox)(-/-) mice, whereas these mice had increased neutrophilic alveolitis and greater lung injury compared with WT controls. In mice interbred with transgenic NF-kappaB reporters (HIV-long terminal repeat/luciferase [HLL]), we found exaggerated LPS-induced NF-kappaB activation and increased expression of proinflammatory cytokines in lungs of p47(phox)(-/-)/HLL mice compared with controls. Both lung macrophages and bone marrow-derived macrophages (BMDMs) isolated from p47(phox)(-/-)/HLL mice showed enhanced LPS-stimulated NF-kappaB activity compared with controls. Although nuclear translocation of NF-kappaB proteins was similar between genotypes, EMSAs under nonreducing conditions showed increased DNA binding in p47(phox)(-/-)/HLL BMDMs, suggesting that ROS production reduces NF-kappaB binding to DNA without affecting nuclear translocation. Increased intracellular reduced glutathione/glutathione disulfide ratio and greater nuclear redox factor 1 (Ref-1) levels were present in p47(phox)(-/-)/HLL compared with WT BMDMs, pointing to NADPH oxidase modulating intracellular redox status in macrophages. Treatment with the Ref-1-specific inhibitor E3330 or hydrogen peroxide inhibited LPS-induced NF-kappaB activation in p47(phox)(-/-)/HLL BMDMs but not in WT/HLL cells. Consistent with these findings, small interfering RNA against Ref-1 selectively reduced NF-kappaB activity in LPS-treated p47(phox)(-/-)/HLL BMDMs. Together, these results indicate that NADPH oxidase limits LPS-induced NF-kappaB transcriptional activity through regulation of intracellular redox state. FAU - Han, Wei AU - Han W AD - Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. wei.han@vanderbilt.edu FAU - Li, Hui AU - Li H FAU - Cai, Jiyang AU - Cai J FAU - Gleaves, Linda A AU - Gleaves LA FAU - Polosukhin, Vasiliy V AU - Polosukhin VV FAU - Segal, Brahm H AU - Segal BH FAU - Yull, Fiona E AU - Yull FE FAU - Blackwell, Timothy S AU - Blackwell TS LA - eng GR - R01 AI079253/AI/NIAID NIH HHS/United States GR - R01 HL061419/HL/NHLBI NIH HHS/United States GR - HL61419/HL/NHLBI NIH HHS/United States GR - AI079253/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20130325 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (Reactive Oxygen Species) RN - EC 1.6.3.- (NADPH Oxidases) RN - EC 4.2.99.18 (Apex1 protein, mouse) RN - EC 4.2.99.18 (DNA-(Apurinic or Apyrimidinic Site) Lyase) SB - IM MH - Animals MH - DNA-(Apurinic or Apyrimidinic Site) Lyase/immunology/metabolism MH - Lipopolysaccharides/*immunology/pharmacology MH - Lung/drug effects/immunology/metabolism MH - Lung Injury/chemically induced/immunology/*metabolism MH - Mice MH - NADPH Oxidases/immunology/*metabolism MH - NF-kappa B/immunology/*metabolism MH - Neutrophils/immunology/metabolism MH - Oxidation-Reduction MH - Pneumonia/chemically induced/immunology/*metabolism MH - Reactive Oxygen Species/immunology/metabolism PMC - PMC3633681 MID - NIHMS450936 EDAT- 2013/03/27 06:00 MHDA- 2013/07/31 06:00 PMCR- 2014/05/01 CRDT- 2013/03/27 06:00 PHST- 2013/03/27 06:00 [entrez] PHST- 2013/03/27 06:00 [pubmed] PHST- 2013/07/31 06:00 [medline] PHST- 2014/05/01 00:00 [pmc-release] AID - jimmunol.1201809 [pii] AID - 10.4049/jimmunol.1201809 [doi] PST - ppublish SO - J Immunol. 2013 May 1;190(9):4786-94. doi: 10.4049/jimmunol.1201809. Epub 2013 Mar 25.